Free Trial

Pharma-Bio Serv Q4 2023 Earnings Report

Pharma-Bio Serv logo
$0.50 +0.07 (+16.28%)
As of 03/31/2025 03:52 PM Eastern

Pharma-Bio Serv EPS Results

Actual EPS
$0.03
Consensus EPS
$0.03
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Pharma-Bio Serv Revenue Results

Actual Revenue
$3.60 million
Expected Revenue
$5.00 million
Beat/Miss
Missed by -$1.40 million
YoY Revenue Growth
N/A

Pharma-Bio Serv Announcement Details

Quarter
Q4 2023
Time
Q4 2023 Earnings Release

Conference Call Resources

Remove Ads

Pharma-Bio Serv Earnings Headlines

Zacks Small Cap Cuts Earnings Estimates for Pharma-Bio Serv
PBSV Returns to Growth
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
See More Pharma-Bio Serv Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Pharma-Bio Serv? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pharma-Bio Serv and other key companies, straight to your email.

About Pharma-Bio Serv

Pharma-Bio Serv (OTCMKTS:PBSV) operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

View Pharma-Bio Serv Profile

More Earnings Resources from MarketBeat